Review article · 2026

Immunogenicity risk assessment of novel modalities using new approach methodologies

Vijaya Lakshmi Simhadri, Sharon Vijayanand, Vibha Jawa, Zuben E. Sauna

Nature Reviews Drug Discovery · Published 13 November 2026 · DOI 10.1038/s41573-026-01562-9

View at the publisherCite this paper

In brief

“Immunogenicity risk assessment of novel modalities using new approach methodologies” is a 2026 review article by Vijaya Lakshmi Simhadri and 3 co-authors, published in Nature Reviews Drug Discovery. OpenAlex counts 0 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
132
Authors
4

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Simhadri, V. L., Vijayanand, S., Jawa, V., & Sauna, Z. E. (2026). Immunogenicity risk assessment of novel modalities using new approach methodologies. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-026-01562-9

MLA 9

Simhadri, Vijaya Lakshmi, et al. “Immunogenicity risk assessment of novel modalities using new approach methodologies.” Nature Reviews Drug Discovery, 2026. https://doi.org/10.1038/s41573-026-01562-9.

Chicago

Simhadri, Vijaya Lakshmi, Sharon Vijayanand, Vibha Jawa, and Zuben E. Sauna. 2026. “Immunogenicity risk assessment of novel modalities using new approach methodologies.” Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-026-01562-9.

Harvard

Simhadri, V. L. et al. (2026) ‘Immunogenicity risk assessment of novel modalities using new approach methodologies’, Nature Reviews Drug Discovery. doi:10.1038/s41573-026-01562-9.

IEEE

V. L. Simhadri, S. Vijayanand, V. Jawa, and Z. E. Sauna, “Immunogenicity risk assessment of novel modalities using new approach methodologies,” Nature Reviews Drug Discovery, 2026, doi: 10.1038/s41573-026-01562-9.

BibTeX

@article{simhadri2026immunogenicity,
  title     = {{Immunogenicity risk assessment of novel modalities using new approach methodologies}},
  author    = {Simhadri, Vijaya Lakshmi and Vijayanand, Sharon and Jawa, Vibha and Sauna, Zuben E.},
  journal   = {Nature Reviews Drug Discovery},
  year      = {2026},
  doi       = {10.1038/s41573-026-01562-9},
  url       = {https://doi.org/10.1038/s41573-026-01562-9}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods

  • immunogenicity risk assessment
  • new approach methodologies
  • gene therapy
  • cell therapy
  • genome editing
  • preclinical safety
  • organ-on-a-chip
  • organoids

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Simhadri, V. L., Vijayanand, S., Jawa, V., & Sauna, Z. E. (2026). Immunogenicity risk assessment of novel modalities using new approach methodologies. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-026-01562-9

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Vijaya Lakshmi Simhadri, Sharon Vijayanand, Vibha Jawa, Zuben E. Sauna.

What is the DOI of this paper?

10.1038/s41573-026-01562-9, permanently at https://doi.org/10.1038/s41573-026-01562-9. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.